Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
SABA · Tocolytic
Ritodrine is a beta2-selective adrenergic agonist. It stimulates beta2 adrenergic receptors, leading to relaxation of uterine smooth muscle.
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
Increased risk of adverse metabolic effects like hyperglycemia.
Ritodrine should not be used if the mother is receiving steroids.
Source: KDT 7e · p333
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team